Amplifon (AMFPF) Stock Price, News & Analysis

Company Overview

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization. The company was listed on the Borsa Italiana in 2001 and has since expanded its footprint through targeted acquisitions and organic growth. Over the decades, Amplifon has integrated complementary businesses and technologies, reinforcing its position in an increasingly competitive global hearing-care market.

Today, Amplifon operates thousands of points of sale across more than 20 countries spanning Europe, North America, Latin America and the Asia-Pacific region. Headquartered in Milan, the company combines local retail expertise with global best practices in audiology, consumer engagement and after-sales support. Its international platform enables consistent service delivery and innovation in hearing solutions tailored to diverse regulatory environments and patient needs.

Key Stats

• Today's Range: $18.33 to $18.33
• 50-Day Range: $17.17 to $23.85
• 52-Week Range: $16.97 to $29.33
• Volume: N/A
• Average Volume: 14 shs
• Market Capitalization: $4.13 billion
• P/E Ratio: 30.05
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

AMFPF Stock Analysis - Frequently Asked Questions

How have AMFPF shares performed this year?

Amplifon's stock was trading at $26.0025 on January 1st, 2025. Since then, AMFPF shares have decreased by 29.5% and is now trading at $18.33.

How were Amplifon's earnings last quarter?

Amplifon S.p.A. (OTCMKTS:AMFPF) posted its quarterly earnings results on Thursday, August, 7th. The company reported $0.25 EPS for the quarter, missing the consensus estimate of $0.34 by $0.09. The business had revenue of $698.20 million for the quarter, compared to analyst estimates of $625.73 million. Amplifon had a trailing twelve-month return on equity of 13.70% and a net margin of 5.20%.

How do I buy shares of Amplifon?

Shares of AMFPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/07/2025
• Today: 9/12/2025
• Next Earnings (Estimated): 10/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:AMFPF
• CIK: N/A
• Web: corporate.amplifon.com
• Phone: (390) 257-4721
• Fax: N/A
• Employees: 15,070
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.61
• Trailing P/E Ratio: 22.91
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $157.31 million
• Net Margins: 5.20%
• Pretax Margin: 8.17%
• Return on Equity: 13.70%
• Return on Assets: 3.85%

Debt

• Debt-to-Equity Ratio: 1.03
• Current Ratio: 0.61
• Quick Ratio: 0.53

Sales & Book Value

• Annual Sales: $2.61 billion
• Price / Sales: 1.59
• Cash Flow: $2.19 per share
• Price / Cash Flow: 8.38
• Book Value: $5.52 per share
• Price / Book: 3.32

Miscellaneous

• Outstanding Shares: 225,500,000
• Free Float: N/A
• Market Cap: $4.13 billion
• Optionable: Not Optionable
• Beta: 0.35